Telo Genomics

Telo Genomics is a Canada medicine company that offers software platform designed to predict the course of certain diseases and to tailor treatment options for the individual patient. The company provides important actionable information to medical professionals in the management of cancer or cognitive disease. Telo Genomics was incorporated in 2011 and is headquartered in Toronto, Canada.
Telo Genomics stock price chart
-58%
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Telo Genomics balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, С$
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Telo Genomics cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Telo Genomics multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Telo Genomics profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Telo Genomics assets
Telo Genomics cash flows

Telo Genomics dividend policy

The company doesn't provide dividend

Telo Genomics shares

TickerNameTypeNominal valueISINPrice
TELO:CNTelo GenomicsCommon share-CA87975M2085CA$0.115
General information
Company nameTelo Genomics
SectorHealth Care / Health Care Equipment & Services / Health Care Technology / Health Care Technology
Business addressMaRS Centre, South Tower 101 College Street, Suite 200 Toronto, ON M5G 1L7 Canada
Mailing addressMaRS Centre, South Tower 101 College Street, Suite 200 Toronto, ON M5G 1L7 Canada
Websitewww.telodx.com